by John A. Jenkins | Jul 17, 2024 | FOIA, Law Firms, SEC, Stock Market
The American Securities Association Uses a FOIA Lawsuit to Advance Its Agenda Two months ago, the two Republican members of the Securities and Exchange Commission blasted their own agency for what they called a meritless prosecution of stock exchanges. In a blunt...
by Randy E. Miller | Jul 3, 2024 | FDA, FOIA, Law Firms, Litigation, Pharmaceuticals
FOIAengine: Law Firm’s 48 Inquiries Follow Earlier Requests Personal injury law firm Morgan & Morgan continued to push the Food and Drug Administration during May for documents that could strengthen potential litigation challenging popular weight control drugs. ...
by John A. Jenkins | Jun 13, 2024 | EPA, FOIA, Law Firms, Litigation, News Media
FOIAengine: ProPublica Reporter Made Dozens of FOIA Requests to EPA Before Dropping a Bombshell Minnesota-based 3M styles itself as a friendly, people-first company in the heartland of America, innovating through curiosity. Its 93,000 employees make all sorts of...
by John A. Jenkins | Jun 6, 2024 | FDA, FOIA, Law Firms, Litigation, Medical Devices
FOIAengine: Hundreds of FOIA Requests Signaled Challenge to FDA Two companies that go by the names of Triton Distribution and Vapetasia are small players in America’s fast-growing $28 billion e-cigarette market. Despite their size, they’ve become the unlikely...
by John A. Jenkins | Apr 3, 2024 | FDA, FOIA, Law Firms, Medical Devices
FOIAengine: Neuralink’s High Profile Makes It a Target It was a Musk Moment unlike any other: Two weeks ago, the first human participant in Neuralink’s brain-implant trials took the stage to show how he could play chess by imagining where he wanted the pieces to go. ...
by Randy E. Miller | Mar 27, 2024 | FDA, FOIA, Hedge Funds, Law Firms, Litigation, Non-Profits, Pharmaceuticals, Politics, Short-Selling, Stock Market
FOIAengine: Conservative Activists, Law Firms, Non-Profits Signal Competing Agendas A review of the most recent Freedom of Information Act requests made to the Food and Drug Administration illustrates how political organizations, law firms, news media, and financial...